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Objective: Cognitive behavior therapy is an effective nonpharmacologic treatment for 
insomnia. However, individualized administration is costly and often results in substantial 
variability in treatment response across individual patients, particularly so for older adults. 
Group-based administration has demonstrated impressive potential for a brief and 
 inexpensive answer to the effective treatment of insomnia in the older population. It is 
important to identify potential predictors of response to such a treatment format to guide 
clinicians when selecting the most suitable treatment for their patients. The aim of our study 
was to identify factors that predict subjective sleep quality of older adults following group-
based administration of cognitive behavior therapy for insomnia (CBT-I). 
Methods: Eighty-six adults (41 men; mean age, 64.10 y; standard deviation [SD], 6.80) with 
sleep maintenance or early morning awakening insomnia were selected from a community-
based sample to participate in a 4-week group-based treatment program of CBT-I. 
Participants were required to complete 7-day sleep diaries and a comprehensive battery of 
questionnaires related to sleep quality and daytime functioning. Hierarchical multiple 
regression analyses were used to identify factors predicting subjective sleep quality 
immediately following treatment and at 3-month follow-up. Sleep diaries reported average 
nightly sleep efficiency (SE), which was used as the outcome measure of sleep quality.  
Results and Conclusions: Participants with the greatest SE following treatment while 
controlling for pretreatment SE were relatively younger and had more confidence in their 
ability to sleep at pretreatment. These characteristics may be useful to guide clinicians when 
considering the use of a group-based CBT-I for sleep maintenance or early morning 




 Chronic insomnia is a highly prevalent and persistent health concern, of which 
research has consistently demonstrated to increase with age [1-4]. In recent years, surveys 
have indicated that approximately 20% to 40% of adults older than 55 years of age reported 
waking a lot during the night, waking too early and not being able to get back to sleep, and 
 waking feeling unrefreshed [5,6]. Chronic insomnia not only significantly impacts the 
psychologic and physiologic well-being of the individual [1,7,8] but also places large 
economic costs and burden on society [9,10]. Therefore, it is not surprising that considerable 
attention has been given to optimizing treatment options in efficacy for the individual and 
also cost-effectiveness for the healthcare system [11,12]. 
 The current treatment of choice for insomnia is cognitive behavior therapy for 
insomnia (CBT-I), which consistently produces significant improvements in most sleep 
variables including wake after sleep onset (WASO) and sleep efficiency (SE) [13-15] for 
70% to 80% of patients [16,17]. Although significant, the changes in sleep variables are 
modest particularly for older adults [11-13]. Furthermore, individual administration of CBT-I 
is costly, not readily available, and can markedly vary in efficacy between individuals [12]. 
Alternatively, group-based administration has demonstrated impressive potential for a brief 
and inexpensive answer to the effective treatment of insomnia in the older population [18,19]. 
 Several research groups have focused on identifying potential factors, which may 
predict treatment outcome in a bid to guide clinicians when selecting the most suitable 
treatment for their patient [20,21]. Characteristics such as the age of the patient [22-24] and 
the severity [11,25,26] and duration [25] of their insomnia have been recognized as predictors 
of treatment outcome. However, the majority of these studies have focused on predictors of 
treatment outcome in younger patients following individualized administration of CBT-I.  
 Few studies have focused on identifying potential predictors of sleep quality 
following group-based administration of CBT-I in the older population. Gagné and Morin 
[12] examined potential predictors of treatment outcome in 18 older adults (mean age, 64.6 y) 
following 8 weekly, 90-minute, group-administered sessions of CBT-I. Treatment outcome 
was defined as the mean (standard error of the mean) reported by participants on their sleep 
diaries during the final 2 weeks of the treatment program. Results indicated that younger age, 
 greater presence of medical illness, and more frequent use of sleeping medication predicted 
the greatest improvement in subjective estimates of SE following treatment. Gagné and 
Morin [12] acknowledged that better treatment outcomes associated with greater presence of 
medical illness and more frequent use of sleeping medications are counter intuitive. They 
concluded that the small sample size of their study warrants further research to establish these 
variables as predictors of treatment efficacy. Additionally, treatment outcome as assessed 
during the final 2 weeks of the treatment program may have reflected responses during the 
treatment itself rather than provide an accurate indication of longer-term posttreatment 
responses to CBT-I.  
In a separate study, Espie et al [11] investigated predictors of treatment outcome in a 
somewhat younger group of 109 adults (mean age, 52.1 y) for 12 months following a group-
administered CBT-I treatment program. Participants attended 6 weekly sessions, each lasting 
for 50 minutes. Espie et al [11] defined a clinically significant treatment outcome as (1) a 
50% reduction in subjective sleep-onset latency (SOL) or WASO relative to pretreatment 
levels or (2) a reduction in SOL or WASO to 30-minutes or less. Reductions in SOL and 
WASO to this criterion level were associated with less severe insomnia at baseline, greater 
symptoms of depression and anxiety, and more dysfunctional worries about sleep.  
Together the aforementioned studies have begun to address the question of the types 
of factors, which may be predictive of the effectiveness of small group–based CBT-I for 
older adults. The aim of our study was to contribute to this effort. The treatment program 
utilized in our study was shorter than the majority of those assessed in previous studies, 
consisting of only 4 weekly sessions, each lasting approximately 60 minutes in duration, 
which is the minimum number of sessions possible to include the most efficacious elements 
of a CBT-I program. Edinger et al [19] have previous demonstrated that 4 biweekly treatment 
sessions produced a favorable long-term outcome. The current program was administered to 
 small groups of 4 to 6 individuals. Our study assessed potential predictors of subjective sleep 
quality both immediately following treatment and at 3-month follow-up to predict the 
maintenance of improvements in sleep quality.  
Both age and a variety of other factors related to insomnia severity and duration were 
assessed as potential predictors of treatment efficacy. Past research has indicated that older 
participants had a poorer treatment response relative to younger participants [22,25], though 
insomnia severity and duration have not yet been consistently related to treatment outcome 
[21,23,25,26,41]. Dysfunctional beliefs and attitudes regarding sleep, sleep-related anxiety, 
and fatigue also were assessed as potential predictors of treatment response. Studies 
conducted by Espie et al [11] and Morin et al [16] suggested that treatment response was not 
influenced by fatigue or sleep-related anxiety; however, more dysfunctional beliefs and 
attitudes about sleep have been associated with greater improvements in sleep quality [11]. 
Chronotype and sleep self-efficacy were included as potential predictors, which have not 
been previously published to the authors’ knowledge. Sleep self-efficacy has been suggested 
to be predictive of adherence to CBT-I [38,39], while low sleep self-efficacy is associated 





Our sample included 86 participants (41 men; mean age, 64.10 y [standard deviation 
[SD, {6.80}]; range, 49–85 y) with chronic sleep maintenance problems or early morning 
awakening difficulties selected from a community-based sample. Participants were assessed 
for eligibility using a semistructured telephone interview, 7-day sleep diaries, several 
questionnaires, and a home-based polysomnography. Participants were included in our study 
 if they (1) experienced WASO of greater than 30 minutes for at least 3 nights per week for a 
reported duration of at least 6-months, or (2) if they experienced impaired daytime 
functioning such as daytime fatigue, irritability, memory difficulties, or difficulty maintaining 
attention. All participants reported no use of sedative or hypnotic medication for at least one 
month prior to their involvement in the study. Participants with clear clinical symptoms of 
other sleep disorders or severe medical or psychiatric disorders were excluded. Participants 
were excluded if they (1) indicated the presence of sleep apnea (apnea hypopnea index >15) 
[35], (2) indicated the presence of major depression, (3) consumed excessive amounts of 
caffeine (>300 mg/d) or alcohol (>2 standard drinks/d), or (4) they scored ≥10 on the 
Geriatric Depression Scale or had a full-scale Wechsler Abbreviated Score of Intelligence 
quotient below 70. The study was approved by the Social and Behavioural Ethics Committee 
of Flinders University.  
 
2.2. Screening measures 
 
 Potential participants were screened for sleep maintenance and early morning 
awakening insomnia using the Pittsburgh Sleep Quality Index [1] in addition to a brief 
semistructured telephone interview about typical sleep timing, daytime functioning, 
medication use, and diagnoses of any sleep disorders. Participants were screened for sleep-
disordered breathing and periodic limb movements using an overnight home-based 
polysomnography recording (Compumedics enhanced Somte portable recorders, Melbourne, 
Victoria). The Geriatric Depression Scale short-form [33] was used to screen for depression, 
while two subscales of the Wechsler Abbreviated Scale of Intelligence [34] were used to 
screen for mild cognitive impairment. 
 
 2.3. Treatment 
 
 Participants attended 4 weekly 60-minute sessions of CBT-I, which were conducted in 
small groups of 4 to 5 individuals. The treatment was a structured multicomponent 
intervention, including bedtime restriction (based on sleep restriction but with modifications 
suggested by Morin [1]),
 
cognitive therapy, and an educational component. Bedtime 
restriction involved restricting the amount of time the participant spent in bed (TIB), which 
should have been as close as possible to their estimated total sleep time (TST) as calculated 
from their sleep diary. At each therapy session, participants’ sleep diaries were reviewed, and 
in cases in which SE (TST/TIB*100) was greater than 90%, TIB was increased by 30 minutes 
for the following week. In cases in which SE was <90%, participants were instructed to 
maintain their current TIB. The cognitive component involved the identification of 
dysfunctional cognitions related to sleep, challenging the validity of these cognitions and 
providing more adaptive and rational substitute cognitions [1]. The education component 
focused on providing participants with basic information about sleep, such as the nature and 
function of sleep, circadian rhythms, sleep needs, and the effects that some sleep disorders 
(i.e., insomnia) can have on the sleep pattern [1]. Sleep hygiene practices also were discussed 
with particular reference to the effect of common substances (i.e., caffeine, alcohol, nicotine), 
diet, exercise, and bedroom environment on sleep. 
Five trainee psychologists (4 women, 1 man) with experience in CBT-I administered 
the therapy sessions. Participants received the same therapist for each therapy session. Each 
therapist was provided with a treatment manual to ensure that participants in each group 
received identical information regardless of the therapist. A one-way analysis of variance 
revealed that the credibility and participant satisfaction with treatment, assessed using the 
Treatment Credibility and Satisfaction Scale [36], did not differ across therapists (P<.28).  
 For all therapists, a clinical psychologist specialized and highly experienced in the 
treatment of insomnia (Dr. Wright) was consulted weekly to discuss clinical issues, to ensure 
proper provision of treatment, and to maintain fidelity of treatment. Two assessors 
independently reviewed video recordings of a subset of 8 randomly chosen therapy sessions 
to assess treatment fidelity. The assessors concluded that the 8 therapy sessions did not differ 
from the treatment manual provided to therapists and that the therapists did not provide any 
additional therapeutic recommendations to participants.  
Participants’ TIB was used as an indicator of treatment compliance. Compliance was 
assessed by examining nightly TIB, as reported on sleep diaries. At each weekly therapy 
session, participants’ sleep diary reports of nightly TIB were compared to those prescribed 
per the bedtime restriction procedure. A 1-way analysis of variance revealed that TIB, as 




2.4.1. Outcome measure 
 Participants were required to complete a sleep diary for 7 days prior to the treatment 
sessions. Participants were asked to provide subjective estimates of their SOL, number and 
duration of awakenings, TST across the night, and the amount of TIB. From these estimates, 
the primary outcome measure (SE) was calculated. The SE was calculated as TST divided by 
total time spent in bed, multiplied by 100 (e.g., 6 h of sleep/8 h TIB *100=75%). As 
recommended by Gagné and Morin [12], sleep diary–reported average nightly SE was used 
as an outcome measure of sleep quality, as it provided the best composite index of insomnia 
severity, it was a reliable measure of improvement in sleep, and it was a continuous variable 
it provides greater power to identify relationships between predictors and sleep quality. 
  
2.4.2. Predictor measures 
 Several variables were examined as potential predictors of subjective SE in the week 
following the last treatment session and at 3-month follow-up. These variables were selected 
based on the findings of previous studies [11,12,20,23,25] and included age, duration of 
insomnia, insomnia severity (as measured by the Insomnia Severity Index
1
), fatigue (as 
measured by the Flinders Fatigue Scale [27]), and overall subjective sleep quality (as 
measured by Pittsburgh Sleep Quality Index [28]). Other variables examined included 
dysfunctional beliefs and attitudes about sleep (DBAS) (as measured the DBAS-16 [29]), 
chronotype (as measured by the Morningness-Eveningness questionnaire [30]), anxiety 
related to sleep (as measured by the Sleep Anticipatory Anxiety Questionnaire [31]), and 
sleep self-efficacy (Sleep Self-Efficacy Scale [32]). All measures were completed by 
participants prior to treatment. The demographic and clinical features of the sample are 
shown in Table 1. 




3.1. Response to treatment 
 
 SE increased 17% on the average from pretreatment (M = 66.06, SD = 12.91) to 
posttreatment (M = 82.81, SD = 10.51; P<.001) and was maintained at 3-month follow up (M 
= 78.76, SD = 11.99; P<.001). Table 2 below shows the distribution of sleep efficiencies 
across participants prior to treatment, immediately following treatment, and at 3-month 
follow up. The proportion of individuals with sleep efficiencies of 85% or above, indicative 
 of good sleep, increased from 1% at pretreatment to over 50% following treatment. Three-
months following treatment, 32% of participants maintained sleep efficiencies within the 
‘good sleeper’ range.  
< Insert Table 2 about here > 
 
3.2. Correlations among predictor variables 
 
 Correlation analyses were conducted to determine associations among the predictor 
variables. The significant correlations between the predictor variables are shown in Table 3 
below. Dysfunctional beliefs and attitudes about sleep, fatigue, insomnia severity, overall 
self-reported sleep quality, and sleep anticipatory anxiety were all positively intercorrelated 
(rs=0.27–0.55; P<.05). Sleep self-efficacy was negatively correlated with fatigue, insomnia 
severity, overall self-reported sleep quality, sleep anticipatory anxiety, and dysfunctional 
beliefs and attitudes about sleep (rs=−0.38 to −0.51; P<.05). Sleep self-efficacy was also 
positively correlated with being more of a morning chronotype (r=.28; P<.05). Age and 
duration of insomnia were not significantly correlated with any other predictor variable. 
< Insert Table 3 about here > 
 
3.3. Predictors of improvement in SE 
 
 Hierarchical multiple regression analyses were used to identify factors predicting 
subjective SE immediately following treatment and at 3-month follow-up. Because there are 
no consistent results from previous research to guide model building, individual regression 
equations were conducted for each potential predictor variable [12]. In each case, subjective 
SE at either posttreatment or 3-month follow-up was entered as the outcome measure. For the 
 first regression equation (coefficients indicated by B), pretreatment SE was entered as a 
covariate to control for initial SE. For the second regression equation (coefficients indicated 
by B2), all other predictor variables in addition to pretreatment SE were entered as covariates.  
 Table 4 presents the simple correlations and standardized regression coefficients from 
hierarchical regression analyses. A significant correlation (r) indicates a significant 
relationship between the predictor variable and SE at either posttreatment or 3-month follow-
up. Improvement of SE following treatment was confirmed by a significant B value (B), 
indicating that the predictor variable of interest explains significant unique variance above 
and beyond that explained by pretreatment SE. Likewise, a significant B2 value indicates that 
the predictor variable of interest explains significant unique variance above and beyond that 
explained by both pretreatment SE and all other predictor variables (B2).  
< Insert Table 4 about here > 
 Age, insomnia severity, self-reported sleep disturbance, and sleep self-efficacy were 
significantly related to SE at posttreatment and 3-month follow-up. However, to assess their 
relation to the improvements from pretreatment, the relationship only shows age as a 
predictor of improvement when pretreatment is controlled in the B column at posttreatment 
times and sleep self-efficacy as a significant predictor of improvement at 3-month follow-up.  
When all other potential predictors are controlled (column B2), age remains a 
significant predictor of posttreatment improvement at both time points. Sleep self-efficacy 
remains a significant unique predictor of improvement at 3-month follow-up. Therefore, 
younger age and higher sleep self-efficacy at pretreatment were significant independent 
predictors of improvement in SE following treatment.  
 
4. Discussion  
 
  Our study assessed potential predictors of improved sleep quality of older adults with 
sleep maintenance or early morning awakening insomnia following a brief group-
administered CBT-I treatment program. Our hope is that the results from our study will 
provide clinicians with a useful guide when considering the use of a brief and inexpensive 
group-based CBT-I treatment program for older patients. Sleep diary–reported average 
nightly SE was used as the outcome measure of sleep quality. Participants who experienced 
the greatest improvement in SE both immediately following CBT-I and at 3-month follow-up 
were younger. Our study also assessed sleep self-efficacy as a predictor of treatment 
response, which to our knowledge is unique to our study. Those participants who reported the 
greatest sleep self-efficacy before treatment also reported the greatest improvement in SE at 
3-month follow-up. Given that sleep self-efficacy is a predictor of improvement in SE 
following treatment, adapting the content of CBT-I to include some motivational 
enhancement techniques [36,37] may be beneficial in maximizing a favorable response to 
treatment. 
 The predictors of treatment outcome identified in our study are similar to some but 
not all of those reported in previous research following group-administered CBT-I in older 
adults [11,12]. Gagné and Morin [12] reported that the younger participants of their older 
sample experienced the greatest improvement of SE following treatment, as in our study. 
However, Espie et al [11] found that participants who experienced the greatest 
improvements in sleep quality were those who reported less severe insomnia at pretreatment. 
We did not find insomnia severity or Pittsburgh Sleep Quality Index to be related to 
improvement with treatment. This discrepancy may be explained by the difference in 
defining the severity of insomnia used by Espie et al [11] in contrast to that used in our study. 
Unlike our study, which defined insomnia severity as the Pittsburgh Sleep Quality Index 
 score, Espie et al [11] defined insomnia severity by summing nightly mean SOL and WASO 
at baseline.  
Duration of insomnia, feelings of fatigue, sleep-related anxiety, dysfunctional beliefs 
and attitudes about sleep, and chronotype were not predictive of treatment outcome in our 
study. With the exception of chronotype, each of these variables has previously been 
investigated as a potential predictor of treatment outcome in older adults. Espie et al [11] and 
Gagné and Morin [12] also found no predictive value in duration of insomnia, feelings of 
fatigue, and sleep-related anxiety. In contrast to our results, previous research by Espie et al 
[11] demonstrated that more dysfunctional worries about sleep were associated with greater 
improvements in sleep quality following CBT-I.  
It is important to recognize the high level of intercorrelation between pretreatment 
variables in these types of studies when interpreting such results [12]. For example, it is 
possible that the relationship between dysfunctional beliefs and attitudes about sleep and 
treatment outcome is mediated by other variables such as insomnia duration or severity.  
 Although these types of analyses can be useful to guide clinicians in selecting the 
most suitable treatment for their patient, findings of this type should be interpreted with 
caution. The predictive factors assessed in our study explained approximately 4% to 12% of 
the variance (indicated by the r value) associated with improved SE. Therefore, these results 
provide modest predictive models of treatment outcome. There are a multitude of potential 
factors beyond the pretreatment characteristics included in our analyses that are likely to 
influence response to treatment, such as support from family, motivation, and readiness for 
change.  
 The characteristics of the sample utilized in our study also have implications for the 
interpretation of these analyses. Our study and the study conducted by Gagné and Morin [12] 
solicited individuals from the community for a clinical research trial. Therefore, it is possible 
 that predictors of treatment outcome could be different in patients who individually seek 
treatment in medical settings compared to those who respond to public notifications or 
advertisements of a clinical research trial. Similarly, our sample comprised primary 
insomniacs with no medical or psychiatric comorbidities. Predictors of treatment outcome for 
these participants may not be generalized to older adults in the broader community with 
insomnia. Future research would benefit not only from assessing predictors of treatment 
outcome in clinical samples but also including measures beyond pretreatment characteristics, 
such as motivation for change and compliance to treatment. 
 Overall, the results of our study suggest that relatively younger insomniacs in the 
older age category and with higher sleep self-efficacy can benefit from brief, small, group-
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 Table 1 
Mean (and standard deviation) and number of subjects (and proportion) for demographic and clinical features of our sample. 
Age 64.10 (6.80) 
Gender (man) 41 (47.7%) 
Duration of insomnia (>5 y) 66 (76.7%) 
Insomnia Severity Index 16.34 (3.83) 
Wake after sleep onset (min) 133 (70.2) 
Flinders Fatigue Scale 14.40 (5.88) 
Pittsburgh Sleep Quality Index 11.87 (2.70) 
Dysfunctional Beliefs and Attitudes about Sleep 43.71 (14.25) 
Morningness-Eveningness Questionnaire 64.82 (7.90) 
Sleep Anticipatory Anxiety Questionnaire 11.64 (4.68) 
Sleep Self-Efficacy Scale 23.40 (6.26) 
Abbreviations: y, years; min, minutes. 
 
  
 Table 2 
Proportion of individuals within each sleep efficiency category at pretreatment, posttreatment, and 3-month follow-up.  
 Pretreatment (n) Posttreatment (n) 3-month follow-up 
(n) 
Sleep efficiency (%)    
85–100 1 53 32 
75–84 26 24 34 
65–74 28 11 22 
55–64 23 5 5 





Correlation matrix of predictor variables. 










DBAS .49** .52** .33** .32** −.38** 
Flinders Fatigue Scale   .47**   −.36** 
Insomnia Severity Index      −.47** 
Morningness-Eveningness      .28* 
Pittsburgh Sleep Quality Index .42** .55**  .27* −.51** 
Sleep Anticipatory Anxiety .32** .34**   −.48** 
Abbreviation: DBAS, dysfunctional beliefs and attitudes about sleep. 
**Correlation is significant at the .01 level (2-tailed) 
*Correlation is significant at the .05 level (2-tailed) 
 
  
 Table 4 




dysfunctional beliefs and 
attitudes about sleep. 
a
 indicates a significant 
relationship between the 
predictor variable and sleep 
efficiency at either 
posttreatment or 3-month 
follow-up. 
b
indicates only age as a 
predictor of improvement at 
both posttreatment times and 
Sleep Self-Efficacy a 
significant predictor at 3-month 
follow-up. 
c
indicates the predictor variable 
of interest explains significant 




indicates P=.06 at the 1-tailed level. 
  Sleep efficiency 














Age −.21d −.18d −.21d −.26d −.22d −.19e 
Duration of insomnia −.07 −.06 −.08 −.04 −.03 −.07 
DBAS −.11 −.10 −.09 −.12 −.12 −.02 
Flinders Fatigue Scale .03 .01 .03 .01 −.02 .06 
Insomnia Severity Index −.20d −.09 −.11 −.26d −.12 −.06 
Morningness-Eveningness  −.03 −.11 −.10 .02 −.07 −.16 
Pittsburgh Sleep Quality Index −.22d −.07 −.11 −.32d −.15 −.09 
Sleep Anticipatory Anxiety .04 .08 .07 −.01 .04 .16 
Sleep Self-Efficacy .07 −.03 −.10 .34d .23d .29d 
